Events

“The Biopharma Sustainability Roundtable and Investor Day are an incredibly good use of my time – providing an excellent opportunity to learn from peers, share best practices, understand trends and get re-energized for the important work we all do. I emerge with practical learnings that I can apply immediately and which I am eager to share with colleagues.”

Upcoming Events

Recent Events

April 8, 2025

BSRT Forum | Sustainable Endotoxin Safety Testing

New biosynthetic methods and a recent USP equivalence ruling are driving the move away from Horseshoe Crab blood-derived testing reagents—impacting biodiversity, innovation, and supply chains. Jay Bolden (Eli Lilly), Adele Cheli (GSK), and Ryan Phelan (Revive & Restore) shared their work making this change happen and previewed the new Horseshoe Crab Scorecard.

February 12, 2025

BSRT Forum | EcoVadis and Business Sustainability Assessment

A conversation with the Co-founder and Co-CEO of EcoVadis, Pierre-François Thaler. EcoVadis was founded in 2007 and has grown into a globally trusted provider of business sustainability ratings, with a network of more than 150,000 rated companies. Pierre-François and team will give insights into their assessment approach, and – very timely – their talks with the European Union regarding the CSDDD.

November 5-6, 2024

2024 Biopharma Sustainability Conference

Hosted by Sanofi, Paris

November 7, 2024

2024 Biopharma Sustainability Investor Day

Hosted by Sanofi, Paris

September 3, 2024

BSRT Forum with RepRisk

RepRisk is one of the world’s leading data providers for ESG and Business Conduct, identifying and assessing material ESG risks for corporations based on purely external sources. RepRisk supports investment and financing decisions by some of the world’s largest banks, asset managers and sovereign wealth funds, and many well-known corporate Ratings, Award Schemes, and Index providers embed RepRisk data in their evaluations, including S&P Dow Jones Indices, Bloomberg, CDP, FTSE Russell, Corporate Knights, and Ethisphere.

June 18, 2024

Regulatory and ESG Policy Outlook for Biopharma

Our 6th annual update with EcoFact on global Regulatory and ESG policy developments. The online forum presented a deep dive into current and emerging ESG regulations that will affect our sector. Reporting requirements, due diligence regulations, climate transition planning, and nature-related risks were all part of the discussion, along with updates on emerging topics like the link between ESG and AI.

June 17, 2024

Biopharma Investor ESG Communications In-Person Workshop

A focused group of Biopharma sustainability leaders and Biopharma sector investors convened for a direct conversation about the sector’s highest priority ESG/Sustainability topics, sparked by initial group survey results. The Workshop provided input towards our next public update of the Biopharma Investor ESG Communications Guidance.

June 5, 2024

Biopharma and Human Rights: The Right to Health

Harold Nusser, a seasoned healthcare executive with global experience in health equity and social business, opened our discussion about Biopharma and Human Rights with a focus on the right to health. Additional perspectives were shared by BSRT colleagues from Hikma, Organon, Pfizer, and Roche.

April 10, 2024

CSRD & Taxonomy Implementation

Jens Reissmann, Project Lead for CSRD at Bayer, shares their project strategy and experience with CSRD and Taxonomy Implementation.

February 6, 2024

Patient Engagement - Making the Connection with ESG

Zack Pemberton-Whiteley, Exec. Director, Global Patient Engagement at Novartis, explores Patient engagement (PE) as a key topic within the ESG landscape, and its connections to long-term success.

October 5, 2023

Biopharma Sustainability Investor Day 2023

Manhattan, NYC

October 3-4, 2023

Biopharma Sustainability Roundtable Annual Meeting 2023

Hosted by Organon, Jersey City

June 13, 2023

BSRT Forum with EcoFact

Our 5th annual update with EcoFact on global regulatory and ESG policy developments and trends salient for the biopharma sector. The discussion focuses on topics where ESG policy and regulation is evolving rapidly and the changes will affect biopharma companies, directly or indirectly.

May 18, 2023

BSRT Forum with IFPW

International Federation of Pharmaceutical Wholesalers (IFPW) — A conversation about their new ESG Framework for Healthcare. In early 2023, IFPW launched its ESG Framework for Healthcare to help create global alignment and consistency across the pharmaceutical sector on how to effectively communicate and report the impact of environmental, social, and corporate governance initiatives that advance the supply chain.